Europe · Macro, forex & crypto · Proactive Investors
Prescient Therapeutics opens $7 million share purchase plan to advance PTX-100
Prescient Therapeutics Ltd (ASX:PTX) has opened its share purchase plan (SPP) targeting up to $7 million to help advance its lead cancer therapy PTX-100 through its ongoing Phase…
Read the full article on Proactive Investors Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.proactiveinvestors.co.uk)